Ilja Nolte

Senior Researcher of Statistical Genetics and Genetic Epidemiology

University Medical Center Groningen
Country flagNetherlands

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (6)

Background/Objectives: Tacrolimus dosing traditionally relies on therapeutic drug monitoring in whole blood, while assessment in plasma may better reflect its effect and reveal overdosing impacting health-related quality of life (HRQoL). Methods: In this cross-sectional study, 898 kidney transplant recipients (KTRs) who were at least 12 months post-transplantation were included. Plasma and whole blood tacrolimus concentrations were compared using Passing–Bablok regression analyses and Bland–Altman plots. Furthermore, the relationship with daily tacrolimus dose and with HRQoL (mental component summary (MCS), physical component summary (PCS)) was explored using linear regression by comparing standardized coefficients. Lastly, mediation analyses explored the effect of various tacrolimus-related side effects on the association between tacrolimus concentrations and HRQoL. Results: Comparison of the methods revealed a constant bias and a slight proportional bias between whole blood and plasma tacrolimus concentrations. The Bland–Altman plots indicated poor agreement with a statistically significant ratio difference (p < 0.001). Both whole blood and plasma concentrations were significantly associated with daily tacrolimus dose (both p < 0.001). Compared to whole blood tacrolimus concentrations, plasma tacrolimus concentration showed a strong negative association with worse HRQoL (PCS: st. β = −0.12, p = 0.01; MCS: st. β = −0.14, p < 0.001). The associations between plasma tacrolimus concentrations and HRQoL were mediated by fatigue severity (proportion mediated on PCS: 67.8%, MCS: 59.5%) and reduced kidney function (proportion mediated on PCS: 16.7%, MCS: 12.9%). Conclusions: In conclusion, compared with whole blood tacrolimus concentrations, plasma tacrolimus concentrations exhibited a negative association with HRQoL in KTRs. Consequently, therapeutic drug monitoring using plasma tacrolimus concentrations may reduce the occurrence of tacrolimus-related toxicity.

Year:

2025

Social behaviour is a heritable, context-dependent trait that changes across social settings and development, influencing wellbeing and mental health. We present the first genome-wide meta-regression study of social behaviour from infancy to early adulthood, leveraging 491,246 repeat measures of low prosocial behaviour and peer/social difficulties in European-ancestry cohorts (N eff =121,777, N ind =73,321). We modelled heterogeneity in genetic effects across social domains, informants, and ages (2–29 years), capturing social context through genomic influences. Six loci were identified, including variation within CADM2 ( p =2.51x10 -9 ). The SNP-based heritability was modest (2–7%), and the genetic architecture of social behaviour multidimensional. Polygenic scores demonstrated predictability and accuracy in independent European-ancestry cohorts and, partially, in African-ancestry cohorts (N ind =16,305). Genetic correlations with later-life and mental health outcomes showed context-dependent patterns. Modelling predicted onsets of associations with social behaviour revealed distinct profiles, as observed for autism, ADHD, depression and schizophrenia, highlighting novel opportunities to genetically proxy developmental trajectories.

Year:

2025

Inflammation is associated with a range of neuropsychiatric symptoms; however, the nature of the causal relationship is unclear. We used complementary non-genetic, genetic risk score (GRS), and Mendelian randomization (MR) analyses to examine whether inflammatory markers are associated with affect, depressive and anxiety disorders, and cognition. We tested in ≈ 55,098 (59% female) individuals from the Dutch Lifelines cohort the concurrent/prospective associations of C-reactive protein (CRP) with: depressive and anxiety disorders; positive/negative affect; and attention, psychomotor speed, episodic memory, and executive functioning. Additionally, we examined the association between inflammatory GRSs (CRP, interleukin-6 [IL-6], IL-6 receptor [IL-6R and soluble IL-6R (sIL-6R)], glycoprotein acetyls [GlycA]) on these same outcomes (N max =57,946), followed by MR analysis examining evidence of causality of CRP on outcomes (N max =23,268). In non-genetic analyses, higher CRP was associated with a depressive disorder, lower positive/higher negative affect, and worse executive function, attention, and psychomotor speed after adjusting for potential confounders. In genetic analyses, CRP GRS was associated with any anxiety disorder (β = 0.002, p = 0.037) whereas GlycA GRS was associated with major depressive disorder (β = 0.001, p = 0.036). Both CRP GRS (β = 0.006, p = 0.035) and GlycA GRS (β = 0.006, p = 0.049) were associated with greater negative affect. Inflammatory GRSs were not associated with cognition, except sIL-6R GRS which was associated with poorer memory (β=-0.009, p = 0.018). There was weak evidence for a CRP-anxiety association using MR (β = 0.12; p = 0.054). Genetic and non-genetic analyses provide consistent evidence for an association between CRP and negative affect. These results suggest that dysregulated immune physiology may impact a broad range of trans-diagnostic affective symptoms.

Year:

2024

Although both short and long sleep duration are associated with elevated hypertension risk, our understanding of their interplay with biological pathways governing blood pressure remains limited. To address this, we carried out genome-wide cross-population gene-by-short-sleep and long-sleep duration interaction analyses for three blood pressure traits (systolic, diastolic, and pulse pressure) in 811,405 individuals from diverse population groups. We discover 22 novel gene-sleep duration interaction loci for blood pressure, mapped to 23 genes. Investigating these genes’ functional implications shed light on neurological, thyroidal, bone metabolism, and hematopoietic pathways that necessitate future investigation for blood pressure management that caters to sleep health lifestyle. Non-overlap between short sleep (12) and long sleep (10) interactions underscores the plausible nature of distinct influences of both sleep duration extremes in cardiovascular health. Several of our loci are specific towards a particular population background or sex, emphasizing the importance of addressing heterogeneity entangled in gene-environment interactions, when considering precision medicine design approaches for blood pressure management.

Year:

2024

Background Low-grade systemic inflammation is implicated in the pathogenesis of various neuropsychiatric conditions affecting mood and cognition. While much of the evidence concerns depression, large-scale population studies of anxiety, affect, and cognitive function are scarce. Importantly, causality remains unclear. We used complementary non-genetic, genetic risk score (GRS), and Mendelian randomization (MR) analyses to examine whether inflammatory markers are associated with affect, depressive and anxiety disorders, and cognitive performance in the Lifelines Cohort; and whether associations are likely to be causal. Methods Using data from up to 55,098 (59% female) individuals from the Dutch Lifelines cohort, we tested the cross-sectional and longitudinal associations of C-reactive protein (CRP) with (i) depressive and anxiety disorders; (ii) positive and negative affect scores, and (iii) five cognitive measures assessing attention, psychomotor speed, episodic memory, and executive functioning (figural fluency and working memory). Additionally, we examined the association between inflammatory marker GRSs (CRP, interleukin-6 [IL-6], IL-6 receptor [IL-6R and soluble IL-6R (sIL-6R)], glycoprotein acetyls [GlycA]) on these same outcomes (N max =57,946), followed by MR analysis examining evidence of causality of CRP on outcomes (N max =23,268). In genetic analyses, all GRSs and outcomes were z-transformed. Results In non-genetic analyses, higher CRP was associated with diagnosis of any depressive disorder, lower positive and higher negative affect scores, and worse performance on tests of figural fluency, attention, and psychomotor speed after adjusting for potential confounders, although the magnitude of these associations was small. In genetic analyses, CRP GRS was associated with any anxiety disorder (β=0.002, p =0.037, N=57,047) whereas GlycA GRS was associated with major depressive disorder (β=0.001, p =0.036; N=57,047). Both CRP GRS (β=0.006, p =0.035, N=57,946) and GlycA GRS (β=0.006, p =0.049; N=57,946) were associated with higher negative affect score. Inflammatory marker GRSs were not associated with cognitive performance, except sIL-6R GRS which was associated with poorer memory performance (β=-0.009, p =0.018, N=36,783). Further examination of the CRP-anxiety association using MR provided some weak evidence of causality (β=0.12; p =0.054). Conclusions Genetic and non-genetic analyses provide consistent evidence for an association between CRP and negative affect. Genetic analyses suggest that IL-6 signaling could be relevant for memory, and that the association between CRP and anxiety disorders could be causal. These results suggest that dysregulated immune physiology may impact a broad range of trans-diagnostic affective symptoms. However, given the small effect sizes and multiple tests conducted, future studies are required to investigate whether effects are moderated by sub-groups and whether these findings replicate in other cohorts.

Year:

2024

Heavy metals are common in our environment, and all individuals are exposed to them to some extent. These toxic metals have several harmful effects on the body, including the kidney, which is a very sensitive organ. Indeed, heavy metal exposure has been linked to an increased risk of chronic kidney disease (CKD) and its progression, which may be explained by the well-established nephrotoxic effects of these metals. In this hypothesis and narrative literature review, we will shed light on the potential role that another highly common problem in patients with CKD, iron deficiency, may play in the damaging effects of heavy metal exposure in this patient group. Iron deficiency has previously been linked with an increased uptake of heavy metals in the intestine due to the upregulation of iron receptors that also take up other metals. Furthermore, recent research suggests a role of iron deficiency in the retention of heavy metals in the kidney. Therefore, we hypothesize that iron deficiency plays a crucial role in the damaging effects of heavy metal exposure in patients with CKD and that iron supplementation might be a strategy to combat these detrimental processes.

Year:

2023

Collaborators (93)

Xiaofeng Zhu

Professor

Case Western Reserve University

UNITED STATES
View details

Harold Snieder

Scientific Staff

University Medical Center Groningen

NETHERLANDS
View details

Tomas Paus

Group leader

BarcelonaBeta Brain Research Center

SPAIN
View details

Amy Bentley

National Human Genome Research Institute

UNITED STATES
View details

Melissa Wake

Professorial Fellow

University of Melbourne

AUSTRALIA
View details

Angelica Ronald

Professor of Psychology and Genetics

University of Surrey

UNITED KINGDOM
View details

Cristina Menni

King’s College London

UNITED KINGDOM
View details

Eveline de Zeeuw

University of Amsterdam

NETHERLANDS
View details

Anni Malmberg

University of Helsinki

FINLAND
View details

Nicholas Wareham

Director

University of Cambridge

UNITED KINGDOM
View details

Robert Plomin

Research Professor in Behavioural Genetics

King’s College London

UNITED KINGDOM
View details

Gibran Hemani

Academic , Professor in Statistical Genetics

University of Bristol

UNITED KINGDOM
View details

George Davey Smith

Academic , Professor of Clinical Epidemiology

University of Bristol

UNITED KINGDOM
View details

Ted Reichborn-Kjennerud

Professor

University of Oslo

NORWAY
View details

Joseph McCormick

James H. Steele Professor

-

UNITED STATES
View details

Alexander Neumann

Researcher

Erasmus University Rotterdam

NETHERLANDS
View details

Sanjeevan Jahagirdar

Max Planck Institute for Psycholinguistics

NETHERLANDS
View details

Alexandra Havdahl

Prof

Norwegian Institute of Public Health

NORWAY
View details

Rosa Bosch

divisió de salut mental althaia xarxa assistencial universitària de manresa manresa

SPAIN
View details

Golam Khandaker

Professor of Psychiatry and Immunology

University of Bristol

UNITED KINGDOM
View details

Carol Wang

University of Western Australia

AUSTRALIA
View details

Gea Drost

University Medical Center Groningen

NETHERLANDS
View details

Kaili Rimfeld

Lecturer (Assistant Professor) in Psychology

Royal Holloway, University of London

UNITED KINGDOM
View details

Vilmundur Gudnason

Professor

University of Iceland

ICELAND
View details

Vincent W. V. Jaddoe

Erasmus MC

NETHERLANDS
View details

Chloe Slaney

University of Bristol

UNITED KINGDOM
View details

Simon R. Cox

Personal Chair of Brain and Cognitive Ageing

University of Edinburgh

UNITED KINGDOM
View details

Eero Vuoksimaa

University of Helsinki

FINLAND
View details

Melissa H Black

Associate Professor

La Trobe University

AUSTRALIA
View details

Jennifer Ann Smith

Professor

University of Michigan

UNITED STATES
View details

Michele F. Eisenga

University of Groningen

NETHERLANDS
View details

Sarah Harris

University of Edinburgh

UNITED KINGDOM
View details

Ching-Ti Liu

Boston University

UNITED STATES
View details

Ko Willems van Dijk

Professor

Leiden University Medical Center

NETHERLANDS
View details

Jordi Sunyer Deu

Chair

Barcelona Institute for Global Health

SPAIN
View details

massimo mangino

Honorary Senior Lecturer

King’s College London

UNITED KINGDOM
View details

Heming Wang

Assistant Professor

Brigham and Women's Hospital

UNITED STATES
View details

Marta Ribases

-

SPAIN
View details

Thomas Bourgeron

Université Paris Diderot

FRANCE
View details

Catharina A. Hartman

-

NETHERLANDS
View details

Heather M Highland

University of North Carolina at Chapel Hill

UNITED STATES
View details

Marcus Dörr

University Medicine Greifswald

GERMANY
View details

Paul de Vries

Assistant Professor

The University of Texas Health Science Center at Houston School of Public Health

UNITED STATES
View details

Lisa de las Fuentes

Professor of Medicine and Biostatistics

Washington University School of Medicine

UNITED STATES
View details

Henning Tiemeier

Professor of Maternal and Child Health

Harvard T.H. Chan School of Public Health

UNITED STATES
View details

Jan Buitelaar

Professor, Principal Investigator

Radboud University Medical Center

NETHERLANDS
View details

Iris M. Heid

University of Regensburg

GERMANY
View details

Rodney Scott

Prof. of Medical Genetics

University of Newcastle Australia

AUSTRALIA
View details

Myriam Fornage

-

UNITED STATES
View details

Changwei Li

Associate Professor

University of Texas Southwestern Medical Center

UNITED STATES
View details

Mary Feitosa

Associate Professor

Washington University School of Medicine

UNITED STATES
View details

Debbie A Lawlor

Academic , Professor of Epidemiology, MRC Investigator and BHF Chair

University of Bristol

UNITED KINGDOM
View details

Nora Fernandez-Jimenez

Assistant Professor in Genetics

University of the Basque Country

SPAIN
View details

Sami Heikkinen

Research Director

University of Eastern Finland

FINLAND
View details

Peter Y Liu

University of California

UNITED STATES
View details

Kari North

Professor

University of North Carolina at Chapel Hill

UNITED STATES
View details

Angela Morgan

University of Melbourne

AUSTRALIA
View details

Kisung Nam

Seoul National University

SOUTH KOREA
View details

Tanja G M Vrijkotte

University of Amsterdam

NETHERLANDS
View details

Jose Ramon Bilbao

Full Professor

University of the Basque Country

SPAIN
View details

Michael Province

Professor, Head Division of Statistical Genomics

Washington University in St. Louis

UNITED STATES
View details

Josep Antoni Ramos-Quiroga

Head of the Deparment of Psychiatry

Hospital Universitari Vall d'Hebron

SPAIN
View details

Mariona Bustamante

Staff scientist

Barcelona Institute for Global Health

SPAIN
View details

Jari Lahti

Professor

University of Helsinki

FINLAND
View details

Christel Middeldorp

Professor

-

NETHERLANDS
View details

Uwe Völker

Professor, Head of Department

Universitätsmedizin Greifswald

GERMANY
View details

Alina Rodriguez

professor

University of Lincoln

UNITED KINGDOM
View details

Quan Sun

Research Assistant Professor

University of Pennsylvania

UNITED STATES
View details

Tarunveer Singh Ahluwalia

Associate Professor

University of Copenhagen

DENMARK
View details

Sheena Reilly

Griffith University

AUSTRALIA
View details

John Attia

University of Newcastle Australia

AUSTRALIA
View details

Marjo-Riitta Jarvelin

Professor

University of Oulu

FINLAND
View details

Henrik Larsson

Professor

Karolinska Institutet

SWEDEN
View details

Nicholette Allred

Wake Forest Baptist Medical Center

UNITED STATES
View details

Mariaelisa Graff

Assistant Professor

University of North Carolina

UNITED STATES
View details

paul lichtenstein

Head of Department

Karolinska Institutet

SWEDEN
View details

Andrew Whitehouse

University of Western Australia

AUSTRALIA
View details

Ebba Du Rietz

Assistant Professor

Karolinska Institutet

SWEDEN
View details

Brian Cade

Investigator

Brigham and Women's Hospital

UNITED STATES
View details

Charlotte Cecil

Associate Professor Biological Psychopathology

Erasmus MC

NETHERLANDS
View details

Johannes Björk

Scientific Staff

University Medical Center Groningen

NETHERLANDS
View details

Dan Stein

Professor and Chair of Psychiatry

University of Cape Town

SOUTH AFRICA
View details

Christine Ecker

Heisenberg Professor

Goethe University Frankfurt

GERMANY
View details

Terho Lehtimäki

University of Tampere

FINLAND
View details

Eivind Ystrom

Professor of personality psychology

University of Oslo

NORWAY
View details

Sven Bölte

Professor, head of the Pediatric Neuropsychiatry Unit

Healthcare Provision, Stockholm County

SWEDEN
View details

Craig Pennell

Professor and Chair Obstetrics and Gynaecology, Professor Maternal Fetal Medicine

Newcastle University

AUSTRALIA
View details

SINA A. GHARIB

University of Washington

UNITED STATES
View details

Teemu Palviainen

University of Helsinki

FINLAND
View details

Jian'an Luan

University of Cambridge

UNITED KINGDOM
View details

Jaakko Kaprio

Research Director

University of Helsinki

FINLAND
View details

Ellen Verhoef

Max Planck Institute for Psycholinguistics

NETHERLANDS
View details

Dorret I Boomsma

Full professor

University of Amsterdam

NETHERLANDS
View details